435 related articles for article (PubMed ID: 9663635)
1. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
Lurie P; Gorsky R; Jones TS; Shomphe L
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
[TBL] [Abstract][Full Text] [Related]
2. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
Lurie P; Jones TS; Foley J
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S45-51. PubMed ID: 9663623
[TBL] [Abstract][Full Text] [Related]
3. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States.
Holtgrave DR; Pinkerton SD; Jones TS; Lurie P; Vlahov D
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S133-8. PubMed ID: 9663636
[TBL] [Abstract][Full Text] [Related]
4. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
[TBL] [Abstract][Full Text] [Related]
5. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France.
Moatti JP; Vlahov D; Feroni I; Perrin V; Obadia Y
Eur Addict Res; 2001 Mar; 7(1):40-5. PubMed ID: 11316925
[TBL] [Abstract][Full Text] [Related]
6. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.
Taussig JA; Weinstein B; Burris S; Jones TS
AIDS; 2000 Jun; 14 Suppl 1():S47-51. PubMed ID: 10981474
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacy syringe exchange program for injection drug users].
Bonnet N
Presse Med; 2006 Dec; 35(12 Pt 1):1811-8. PubMed ID: 17159732
[TBL] [Abstract][Full Text] [Related]
8. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
[TBL] [Abstract][Full Text] [Related]
9. Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City.
Crawford ND; Amesty S; Rivera AV; Harripersaud K; Turner A; Fuller CM
Am J Public Health; 2013 Sep; 103(9):1579-82. PubMed ID: 23865644
[TBL] [Abstract][Full Text] [Related]
10. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users.
Riley ED; Kral AH; Stopka TJ; Garfein RS; Reuckhaus P; Bluthenthal RN
J Urban Health; 2010 Jul; 87(4):534-42. PubMed ID: 20526690
[TBL] [Abstract][Full Text] [Related]
11. The role of needle exchange programs in HIV prevention.
Vlahov D; Junge B
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.
Zaller N; Jeronimo A; Bratberg J; Case P; Rich JD
J Urban Health; 2010 Dec; 87(6):942-53. PubMed ID: 21116724
[TBL] [Abstract][Full Text] [Related]
13. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
Wright-De Agüero L; Weinstein B; Jones TS; Miles J
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632
[TBL] [Abstract][Full Text] [Related]
14. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut.
Khoshnood K; Blankenship KM; Pollack HA; Roan CT; Altice FL
AIDS Public Policy J; 2000; 15(3-4):88-94. PubMed ID: 12189714
[TBL] [Abstract][Full Text] [Related]
15. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
Pollini RA
J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658
[TBL] [Abstract][Full Text] [Related]
16. Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.
Rudolph AE; Crawford ND; Ompad DC; Benjamin EO; Stern RJ; Fuller CM
J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):140-7. PubMed ID: 20199954
[TBL] [Abstract][Full Text] [Related]
17. Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA.
Siddiqui SS; Armenta RF; Evans JL; Yu M; Cuevas-Mota J; Page K; Davidson P; Garfein RS
Int J Drug Policy; 2015 Nov; 26(11):1150-7. PubMed ID: 26252980
[TBL] [Abstract][Full Text] [Related]
18. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal?
Remis RS; Bruneau J; Hankins CA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S57-9. PubMed ID: 9663625
[TBL] [Abstract][Full Text] [Related]
19. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
Sarang A; Rhodes T; Platt L
Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
[TBL] [Abstract][Full Text] [Related]
20. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K
Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]